On the above Weekly chart price action has corrected almost 90% since August 2021. A number of reasons now exist to be bullish , including: 1) A strong buy signal prints (not shown). 2) Regular bullish divergence . 3) Price action confirms support on past resistance. 4) Falling wedge breakout + backtest. Is it possible price action falls further? Sure. Is it...
CLSD has been beaten like the redheaded step child over the last few months, but yesterday 2/24 may have been the bottom. Looking at the long term chart, this is a huge support level. RSI reading extreme oversold levels. Should be good for a bounce.
I was just looking at clsd and discovered this, much to my amazement. If you missed round one and round two, try for round three. Good luck and trade safely!
CLSD: Clearside Biomedical, Inc. 2021-06-15 07:05:00 Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD
Uptrend Consolidation SMA200 as support OBV> OBV34 WR% Crossed -80 Entry 2.47 Stop 2 Target 4.3 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan with small cost.
Entry price : 3.80 Fundamentals : - Sector: Medical - Biotech - EPS % Chg (Last Qtr): 70% - EPS % Chg (Previous Qtr): 15% - 3 Year EPS Growth Rate: 0% - EPS Est % Chg (Current Yr): 0% - Sales % Chg (Last Qtr): 2334% - Sales % Chg (Previous Qtr): 687% - 3-Year Sales Growth Rate: 265% - Annual Pre -Tax Margin: -1416%
Should close near the upper resistance, to about 4.15. I see a cup and handle. Do you see the same?
To reiterate the notes on the chart, the stock is pushing up against resistance and setting up a major breakout. Tremendous upside potential, however there is always downside risk. Given a potential for upside into the 7-9 range, I'm willing to roll the dice.
Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White,...
Holding shares of this one, still has room to gain off that IHS imo.
Possible wedge break here, along with IHS.
Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White,...
Never have we seen CLSD cross on the weekly RSI to oversold. CLSD made new lows. The more I look at it, the more this looks like a possible bottom as the big picture shows a possible 5th elliot wave + if a possible wyckoff spring. Buy when there is blood on the streets? 2 year hold?